HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
VCEL
Vericel Corporation
VCEL's fundamentals are strong and it looks cheap: trading at 88x earnings, about a third of its usual 280x. Analysts expect strong earnings growth.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
VCEL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
VCEL's revenue, profitability, cash flow and balance sheet are all currently healthy.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
VCEL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 67x | $57.42 | — |
| Current | 88x | $57.42 | — |
| Cheap | 106x | $68.69 | +20% |
| Fair | 277x | $180 | +214% |
| Expensive | 1,180x | $767 | +1236% |
Historical ranges are pointers, not guarantees.
VCEL's PE is in its cheap range at 88x. If earnings grow as analysts expect, today's price would be 67x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
VCEL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
VCEL has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
VCEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | +32% |
| Q3 2026 | $0.65 | +150% |
| Q2 2026 | $0.48 | +243% |
| Q1 2026 | $0.43 | +760% |
| Q4 2025 | $0.32 | +60% |
| Q3 2025 | $0.26 | +225% |
| Q2 2025 | $0.14 | +600% |
| Q1 2025 | $0.05 | +400% |
| Q4 2024 | $0.20 | +$0.27 |
VCEL has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over VCEL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
VCEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $85.4M | +26% |
| Q2 2026 | $77.5M | +22% |
| Q1 2026 | $68.4M | +30% |
| Q4 2025 | $92.9M | +23% |
| Q3 2025 | $67.5M | +17% |
| Q2 2025 | $63.2M | +20% |
| Q1 2025 | $52.6M | +2.6% |
| Q4 2024 | $75.4M | +16% |
VCEL's revenue has grown year over year for 17 quarters in a row: $85M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +9.2 points |
| Q2 2026 | 0.6% | +3.8 points |
| Q1 2026 | -12% | +13 points |
| Q4 2025 | 24% | -0.4 points |
| Q3 2025 | 5.1% | +9.4 points |
| Q2 2025 | -3.2% | +8.2 points |
| Q1 2025 | -24% | -14 points |
| Q4 2024 | 25% | +4.9 points |
VCEL has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over VCEL on cash flow, with more consistent year-over-year improvement.
VCEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15.7M | -19% |
| Q2 2026 | $14.3M | +17504% |
| Q1 2026 | $15.1M | +$22.7M |
| Q4 2025 | $12.8M | +52% |
| Q3 2025 | $19.5M | +$28.7M |
| Q2 2025 | $81K | -95% |
| Q1 2025 | -$7.6M | -$797K |
| Q4 2024 | $8.5M | +276% |
VCEL generated $58M in free cash flow over the past year, up 184% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over VCEL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
VCEL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +650K shares |
| 1 year | +2% | +1.1M shares |
| 3 years | +11% | +5.3M shares |
| 5 years | +13% | +6.3M shares |
| Available history | +20% | +8.8M shares |
VCEL has 53M diluted shares, up 2% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
VCEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.3x | Net Cash |
| Q2 2026 | -4.0x | Net Cash |
| Q1 2026 | -3.9x | Net Cash |
| Q4 2025 | -4.4x | Net Cash |
| Q3 2025 | -5.9x | Net Cash |
| Q2 2025 | -8.5x | Net Cash |
| Q1 2025 | -18.4x | Net Cash |
| Q4 2024 | -7.4x | Net Cash |
VCEL has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
VCEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.1 | Overbought |
| Stochastic | 69.5 | Neutral |
VCEL's weekly RSI is 75 (overbought) and its Stochastic is 70 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
VCEL PE vs Healthcare Sector
| Metric | VCEL | Sector median | Relative |
|---|---|---|---|
| PE | 88x | 26x | 242% above |
| PE % | 10 | 29 | 19 pts below |
VCEL is trading at 88x earnings, a 242% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
VCEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.4 | 29% above |
| 20 week MA | $43.9 | 31% above |
| 50 week MA | $39.0 | 47% above |
| 100 week MA | $41.0 | 40% above |
| 200 week MA | $40.5 | 42% above |
VCEL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
VCEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.5 | $29.0 | +66% |
| 2021 | $29.0 | $41.6 | +44% |
| 2022 | $41.6 | $23.8 | -43% |
| 2023 | $23.8 | $35.6 | +49% |
| 2024 | $35.6 | $57.3 | +61% |
| 2025 | $57.3 | $37.7 | -34% |
| 2026 YTD | $37.7 | $57.4 | +52% |
VCEL has the edge over HIMS on returns for 2026, with the stronger performance.